Lung cancer is a fatal disease that accounts for 14% of new cancer cases. Metastasis is the primary cause of death in patients with lung cancer. Epithelial-mesenchymal transition (EMT) contributes to lung cancer invasion and metastasis. Therefore, it ...
Lung cancer is a fatal disease that accounts for 14% of new cancer cases. Metastasis is the primary cause of death in patients with lung cancer. Epithelial-mesenchymal transition (EMT) contributes to lung cancer invasion and metastasis. Therefore, it is crucial to find appropriate therapy for lung cancer and EMT.
Ethacrynic acid (ECA) is a diuretic that inhibits cellular ion flux that leads to an increase in intracellular Na concentrations.
We studied the effects of ethacrynic acid (ECA) on sphingosylphosphorylcholine (SPC)-induced EMT in A549 lung cancer cells by RT-PCR, Western blot, and RNA sequencing.
We found that ECA inhibits SPC-induced EMT in A549 lung cancer cells. ECA inhibited SPC-induced migration and invasion in A549 lung cancer cells. We identified norrin (NDP) and Wnt2 as ECA responsive genes in A549 lung cancer cells through transcriptome analysis by RNA seq. NDP and WNT2 were validated by RT-PCR. NDP is found to be involved in SPC-induced WNT activation by NDP si-RNA.
These results suggested that ECA suppresses SPC-induced EMT of A549 lung cancer cells via downregulation of NDP expression and ECA might be used as an anti-metastatic drug for lung cancer.